Loading: 100%
Minerva Neurosciences, Inc. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees (as per )no data available
Sector Biotechnology, HealthcareBiotechnology, Healthcareno data available
Ticker NERVno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 170481216
datesClosing price (adj.)
13.10.20177.25
11.10.20177.75
04.10.20177.70
27.09.20176.95
20.09.20177.35
13.09.20177.30
06.09.20177.00
30.08.20176.15
23.08.20175.90
16.08.20176.40
09.08.20176.70
02.08.20176.70
26.07.20177.45
19.07.20178.20
12.07.20178.75
05.07.20179.65
27.06.20178.60
20.06.20179.70
13.06.20179.55
06.06.20179.20
30.05.20178.55
23.05.20177.30
16.05.20178.00
09.05.20176.80
02.05.20177.25
25.04.20177.10
18.04.20177.10
11.04.20177.35
04.04.20177.45
28.03.20178.65
21.03.20177.65
14.03.20178.50
07.03.20178.65
28.02.20178.75
21.02.20179.40
14.02.201710.60
07.02.201710.15
31.01.201710.60
24.01.201710.30
17.01.201710.95
10.01.201712.15
03.01.201711.75
27.12.201612.25
19.12.201613.45
12.12.201613.40
05.12.201613.25
28.11.201613.55
21.11.201613.80
14.11.201613.80
07.11.201610.55
31.10.201611.15
24.10.201612.60
17.10.201612.30
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
7.25n/a
Market Capitalisation
in million USD
252n/a
Enterprise Value
in million USD
165n/a
Common Shares Outstanding
as per Jul 29, 2016
34,805,313n/a
Preferred Shares Outstanding
as per Jul 29, 2016
n/a
Average Basic Shares Outstanding
TTM
26,459,019n/a
Average Diluted Shares Outstanding
TTM
n/a
Index Membership
n/a
Business Summary
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system, or CNS, diseases.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 97n/a
Receivables 0n/a
Total Current Assets 97n/a
PP&E 0n/a
Total Assets 147n/a
Accounts Payable 1n/a
Current Debt 4n/a
Total Current Liabilities 6n/a
Long-Term Debt 6n/a
Total Liabilities 26n/a
Total Equity 121n/a
Cash Flow
Depreciation & Amortisation 0n/a
Change in Working Capital 0n/a
Operating Cash Flow -24n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow 14n/a
Dividends Paid 0n/a
Financing Cash Flow 77n/a
Total Change in Cash 67n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share 4.56n/a
FCF per Share n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value 1.59n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 0.48n/a
Other Ratios
Current Ratio 1,561.5%n/a
Liabilities to Equity Ratio 21.5%n/a
Debt to Assets Ratio 6.9%n/a
Profit & Loss StatementP&L data quality: 15% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '13FY '14FY '15
Revenue
0
0
0
Sales & Services Revenue
0
0
0
Financing Revenue
0
0
0
Other Revenue
0
0
0
Cost of revenue
0
0
0
Cost of Goods & Services
0
0
0
Cost of Financing Revenue
0
0
0
Cost of Other Revenue
0
0
0
Gross Profit
0
0
0
Other Operating Income
0
0
0
Operating Expenses
-3
-55
-26
Selling, General & Administrative
-2
-12
-8
Selling & Marketing
0
0
0
General & Administrative
0
0
0
Research & Development
-1
-43
-19
Depreciation & Amortization
0
0
0
Provision For Doubtful Accounts
0
0
0
Other Operating Expense
0
0
0
Operating Income (Loss)
-3
-55
-26
Non-Operating Income (Loss)
0
2
1
Interest Expense, net
0
2
1
Interest Expense
0
0
0
Interest Income
0
0
0
Other Investment Income (Loss)
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
Income (Loss) from Affiliates
0
0
0
Other Non-Operating Income (Loss)
0
0
0
Pretax Income (Loss), Adjusted
-3
-53
-25
Abnormal Gains (Losses)
0
0
0
Acquired In-Process R&D
0
0
0
Merger / Acquisition Expense
0
0
0
Abnormal Derivatives
0
0
0
Disposal of Assets
0
0
0
Early extinguishment of Debt
0
0
0
Asset Write-Down
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
Sale of Business
0
0
0
Legal Settlement
0
0
0
Restructuring Charges
0
0
0
Sale of and Unrealized Investments
0
0
0
Insurance Settlement
0
0
0
Other Abnormal Items
0
0
0
Pretax Income (Loss)
-3
-53
-25
Income Tax (Expense) Benefit, net
0
0
0
Current Income Tax
0
0
0
Deferred Income Tax
0
0
0
Tax Allowance/Credit
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
Income (Loss) from Continuing Operations
-3
-53
-25
Net Extraordinary Gains (Losses)
0
0
0
Discontinued Operations
0
0
0
XO & Accounting Charges & Other
0
0
0
Income (Loss) Including Minority Interest
-3
-53
-25
Minority Interest
0
0
0
Net Income
-3
-53
-25
Preferred Dividends
0
0
0
Other Adjustments
0
0
0
Net Income Available to Common Shareholders
-3
-53
-25
Remarks
restated on Mar 26, 2015 n/a
calculated values,
restated on Mar 14, 2016 n/a
calculated values,
restated on Mar 14, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
2
19
32
Cash & Cash Equivalents
2
19
14
Short Term Investments
0
0
18
Accounts & Notes Receivable
0
0
0
Accounts Receivable, Net
0
0
0
Notes Receivable, Net
0
0
0
Unbilled Revenues
0
0
0
Inventories
0
0
0
Raw Materials
0
0
0
Work In Process
0
0
0
Finished Goods
0
0
0
Other Inventory
0
0
0
Other Short Term Assets
0
1
1
Prepaid Expenses
0
1
1
Derivative & Hedging Assets
0
0
0
Assets Held-for-Sale
0
0
0
Deferred Tax Assets
0
0
0
Income Taxes Receivable
0
0
0
Discontinued Operations
0
0
0
Miscellaneous Short Term Assets
0
0
0
Total Current Assets
2
19
33
Property, Plant & Equipment, Net
0
0
0
Property, Plant & Equipment
0
0
0
Accumulated Depreciation
0
0
0
Long Term Investments & Receivables
0
0
0
Long Term Investments
0
0
0
Long Term Marketable Securities
0
0
0
Long Term Receivables
0
0
0
Other Long Term Assets
27
49
49
Intangible Assets
19
34
34
Goodwill
8
15
15
Other Intangible Assets
0
0
0
Prepaid Expense
0
0
0
Deferred Tax Assets
0
0
0
Derivative & Hedging Assets
0
0
0
Prepaid Pension Costs
0
0
0
Discontinued Operations
0
0
0
Investments in Affiliates
0
0
0
Miscellaneous Long Term Assets
0
0
0
Total Noncurrent Assets
27
49
49
Total Assets
29
68
83
Liabilities and owners' equity
Payables & Accruals
1 1338220
4 3509491
4 3885207
Accounts Payable
1 522981
1 641813
1 1360569
Accrued Taxes
0 0
0 0
0 0
Interest & Dividends Payable
0 0
0 0
0 0
Other Payables & Accruals
1 815239
3 2867678
3 2524638
Short Term Debt
0 58270
0 0
1 1434756
Short Term Borrowings
0 0
0 0
0 0
Short Term Capital Leases
0 0
0 0
0 0
Current Portion of Long Term Debt
0 0
0 0
0 0
Other Short Term Liabilities
0 10093
0 0
0 0
Deferred Revenue
0 0
0 0
0 0
Derivatives & Hedging
0 10093
0 0
0 0
Deferred Tax Liabilities
0 0
0 0
0 0
Discontinued Operations
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
0 0
0 0
0 0
Total Current Liabilities
1 1406583
4 3509491
5 5319963
Long Term Debt
0 0
0 0
9 8503111
Long Term Borrowings
0 0
0 0
0 0
Long Term Capital Leases
0 0
0 0
0 0
Other Long Term Liabilities
8 7588600
13 13441454
13 13433760
Accrued Liabilities
0 0
0 0
0 0
Pension Liabilities
0 0
0 0
0 0
Pensions
0 0
0 0
0 0
Other Post-Retirement Benefits
0 0
0 0
0 0
Deferred Compensation
0 0
0 0
0 0
Deferred Revenue
0 0
0 0
0 0
Deferred Tax Liabilities
8 7588600
13 13433760
13 13433760
Derivatives & Hedging
0 0
0 0
0 0
Discontinued Operations
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
0 0
0 7694
0 0
Total Noncurrent Liabilities
8 7588600
13 13441454
22 21936871
Total Liabilities
9 8995183
17 16950945
27 27256834
Preferred Equity
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
38 38009394
126 126230825
157 157132419
Common Stock
0 0
0 0
0 0
Additional Paid in Capital
0 0
0 0
0 0
Other Share Capital
0 0
0 0
0 0
Treasury Stock
0 0
0 0
0 0
Retained Earnings
-18 -17829791
-75 -74731230
-102 -101812862
Other Equity
0 0
0 0
0 0
Equity Before Minority Interest
20 20179603
51 51499595
55 55319557
Minority Interest
0 0
0 0
0 0
Total Equity
20 20179603
51 51499595
55 55319557
Total Liabilities & Equity
29 29174786
68 68450540
83 82576391
Remarks restated on Mar 26, 2015 n/a restated on Mar 14, 2016 n/a restated on Aug 4, 2016 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '13FY '14FY '15
Net Income/Starting Line
-3
-57
-27
Net Income
0
0
0
Net Income From Discontinued Operations
0
0
0
Other Adjustments
0
0
0
Depreciation & Amortization
0
0
0
Non-Cash Items
1
20
3
Stock-Based Compensation
0
0
0
Deferred Income Taxes
0
0
0
Other Non-Cash Adjustments
0
0
0
Change in Working Capital
0
1
0
(Increase) Decrease in Accounts Receivable
0
0
0
(Increase) Decrease in Inventories
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
Increase (Decrease) in Other
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
Cash from Operating Activities
-2
-36
-24
Change in Fixed Assets & Intangibles
0
0
0
Disposition of Fixed Assets & Intangibles
0
0
0
Disposition of Fixed Assets
0
0
0
Disposition of Intangible Assets
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
Purchase of Fixed Assets
0
0
0
Acquisition of Intangible Assets
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
Net Change in Long Term Investment
0
0
-18
Decrease in Long Term Investment
0
0
0
Increase in Long Term Investment
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
Net Cash from Divestitures
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
Cash for Joint Ventures
0
0
0
Net Cash from Other Acquisitions
0
0
0
Other Investing Activities
0
1
0
Net Cash From Discontinued Operations (investing)
0
0
0
Cash from Investing Activities
0
1
-18
Dividends Paid
0
0
0
Cash From (Repayment of) Debt
3
24
41
Cash From (Repayment of) Short Term Debt, net
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
Repayments of Long Term Debt
0
0
0
Cash From Long Term Debt
0
0
0
Cash From (Repurchase of) Equity
0
31
0
Increase in Capital Stock
0
31
0
Decrease in Capital Stock
0
0
0
Other Financing Activities
1
-3
-2
Net Cash From Discontinued Operations (financing)
0
0
0
Cash from Financing Activities
4
52
38
Net Cash Before Disc. Operations and FX
2
17
-4
Change in Cash from Disc. Operations and Other
0
0
0
Net Cash Before FX
2
17
-4
Effect of Foreign Exchange Rates
0
0
0
Net Changes in Cash
2
17
-4
Remarks
restated on Mar 26, 2015 n/a
calculated values,
restated on Mar 14, 2016 n/a
calculated values,
restated on Mar 14, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo